» Articles » PMID: 17804665

Siderophore-based Iron Acquisition and Pathogen Control

Overview
Specialty Microbiology
Date 2007 Sep 7
PMID 17804665
Citations 609
Authors
Affiliations
Soon will be listed here.
Abstract

High-affinity iron acquisition is mediated by siderophore-dependent pathways in the majority of pathogenic and nonpathogenic bacteria and fungi. Considerable progress has been made in characterizing and understanding mechanisms of siderophore synthesis, secretion, iron scavenging, and siderophore-delivered iron uptake and its release. The regulation of siderophore pathways reveals multilayer networks at the transcriptional and posttranscriptional levels. Due to the key role of many siderophores during virulence, coevolution led to sophisticated strategies of siderophore neutralization by mammals and (re)utilization by bacterial pathogens. Surprisingly, hosts also developed essential siderophore-based iron delivery and cell conversion pathways, which are of interest for diagnostic and therapeutic studies. In the last decades, natural and synthetic compounds have gained attention as potential therapeutics for iron-dependent treatment of infections and further diseases. Promising results for pathogen inhibition were obtained with various siderophore-antibiotic conjugates acting as "Trojan horse" toxins and siderophore pathway inhibitors. In this article, general aspects of siderophore-mediated iron acquisition, recent findings regarding iron-related pathogen-host interactions, and current strategies for iron-dependent pathogen control will be reviewed. Further concepts including the inhibition of novel siderophore pathway targets are discussed.

Citing Articles

Flavin-containing siderophore-interacting protein of Shewanella putrefaciens DSM 9451 reveals common structural and functional aspects of ferric-siderophore reduction.

Trindade I, Fonseca B, Catarino T, Matias P, Moe E, Louro R J Biol Inorg Chem. 2025; .

PMID: 40080164 DOI: 10.1007/s00775-025-02106-z.


Self-growth suppression in is caused by a diffusible antagonist.

Sandhu A, Fischer B, Subramanian S, Hoppe A, Brozel V ISME Commun. 2025; 5(1):ycaf032.

PMID: 40071143 PMC: 11896636. DOI: 10.1093/ismeco/ycaf032.


Exploring the plant growth promoting attributes of pteridophyte-associated microbiome for agricultural sustainability.

Swain S, Nayak S, Mishra S, Ghana M, Dash D Physiol Mol Biol Plants. 2025; 31(2):211-232.

PMID: 40066462 PMC: 11890681. DOI: 10.1007/s12298-025-01553-x.


Antibiotic resistance and virulence profile of isolated from wild Sumatran Orangutans ().

Afiff U, Hidayat R, Indrawati A, Sunartatie T, Hardiati A, Rotinsulu D J Adv Vet Anim Res. 2025; 11(4):1066-1075.

PMID: 40013287 PMC: 11855422. DOI: 10.5455/javar.2024.k858.


Contribution of fepA, fciABC, sbaA, sbaBCDEF, and feoB to ferri-stenobactin acquisition in Stenotrophomonas maltophilia KJ.

Yeh T, Lu H, Li L, Lin Y, Yang T BMC Microbiol. 2025; 25(1):91.

PMID: 40000954 PMC: 11852561. DOI: 10.1186/s12866-025-03792-0.


References
1.
Stefanska A, Fulston M, Jones J, Warr S . A potent seryl tRNA synthetase inhibitor SB-217452 isolated from a Streptomyces species. J Antibiot (Tokyo). 2001; 53(12):1346-53. DOI: 10.7164/antibiotics.53.1346. View

2.
Luo M, Fadeev E, Groves J . Mycobactin-mediated iron acquisition within macrophages. Nat Chem Biol. 2006; 1(3):149-53. DOI: 10.1038/nchembio717. View

3.
Adjimani J, Emery T . Iron uptake in Mycelia sterilia EP-76. J Bacteriol. 1987; 169(8):3664-8. PMC: 212448. DOI: 10.1128/jb.169.8.3664-3668.1987. View

4.
Georgatsou E, Alexandraki D . Regulated expression of the Saccharomyces cerevisiae Fre1p/Fre2p Fe/Cu reductase related genes. Yeast. 1999; 15(7):573-84. DOI: 10.1002/(SICI)1097-0061(199905)15:7<573::AID-YEA404>3.0.CO;2-7. View

5.
Quiocho F, Ledvina P . Atomic structure and specificity of bacterial periplasmic receptors for active transport and chemotaxis: variation of common themes. Mol Microbiol. 1996; 20(1):17-25. DOI: 10.1111/j.1365-2958.1996.tb02484.x. View